NCT03837119View on ClinicalTrials.gov

Maternal and Perinatal Pregnancy Outcome in Women With Heterozygous Hemoglobinopathies

CompletedOBSERVATIONAL
Enrollment

540

Participants

Timeline

Start Date

April 4, 2018

Primary Completion Date

April 11, 2021

Study Completion Date

April 11, 2021

Conditions
Heterozygous Haemoglobinopathy
Interventions
OTHER

pregnancy outcome

descriptive statistics of variables

Trial Locations (2)

4031

Frauenklinik University Hospital Basel, Basel

8091

Frauenklinik University Hospital Zürich, Zurich

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT03837119 - Maternal and Perinatal Pregnancy Outcome in Women With Heterozygous Hemoglobinopathies | Biotech Hunter | Biotech Hunter